FAU.de
Deutsch
Login
Home
Publications
Research Grants
Inventions & Patents
Awards
Additional Research Activities
Faculties & Institutions
Research Areas
UC San Diego School of Medicine
University / College
Location:
La Jolla, CA, United States (USA) (US)
ISNI
: -
Publications
(12)
Types of publications
Toggle all
Journal article
Journal article
Book chapter / Article in edited volumes
Book chapter / Article in edited volumes
Authored book
Authored book
Translation
Translation
Thesis
Thesis
Edited Volume
Edited Volume
Conference contribution
Conference contribution
Other publication type
Other publication type
Unpublished / Preprint
Unpublished / Preprint
Publication year
From
To
Abstract
Journal
Filters (inactive)
Immune mechanisms of depression in rheumatoid arthritis (2023)
Brock J, Basu N, Schlachetzki JC, Schett G, McInnes IB, Cavanagh J
Journal article, Review article
Chronic peripheral inflammation: A possible contributor to neurodegenerative diseases (2021)
Süß P, Lana AJ, Schlachetzki JC
Journal article, Review article
Recent smell loss is the best predictor of COVID-19 among individuals with recent respiratory symptoms (2021)
Gerkin RC, Ohla K, Veldhuizen MG, Joseph PV, Kelly CE, Bakke AJ, Steele KE, et al.
Journal article
Author Correction: A monocyte gene expression signature in the early clinical course of Parkinson’s disease (Scientific Reports, (2018), 8, 1, (10757), 10.1038/s41598-018-28986-7) (2020)
Schlachetzki J, Prots I, Tao J, Chun HB, Saijo K, Gosselin D, Winner B, et al.
Journal article, Erratum
More Than Smell-COVID-19 Is Associated With Severe Impairment of Smell, Taste, and Chemesthesis (2020)
Parma V, Ohla K, Veldhuizen MG, Niv MY, Kelly CE, Bakke AJ, Cooper KW, et al.
Journal article
A monocyte gene expression signature in the early clinical course of Parkinson's disease (vol 8, 10757, 2018) (2020)
Winner B, Schlachetzki JC, Prots I, Tao J, Chun HB, Saijo K, Gosselin D, et al.
Journal article, Erratum
Chronic Peripheral Inflammation Causes a Region-Specific Myeloid Response in the Central Nervous System (2020)
Süß P, Hoffmann A, Rothe T, Ouyang Z, Baum W, Staszewski O, Schett G, et al.
Journal article
SECUKINUMAB PROVIDES SUSTAINED IMPROVEMENTS IN THE SIGNS AND SYMPTOMS OF ACTIVE PSORIATIC ARTHRITIS: 3-YEAR EFFICACY AND SAFETY RESULTS FROM PHASE 3 FUTURE 1 TRIAL (2017)
Mease PJ, Kavanaugh A, Reimold A, Tahir H, Rech J, Hall S, Geusens P, et al.
Conference contribution
Secukinumab Provides Sustained Improvements in the Signs and Symptoms of Active Psoriatic Arthritis through 3 Years: Efficacy and Safety Results from a Phase 3 Trial (2016)
Mease PJ, Kavanaugh A, Reimold A, Tahir H, Rech J, Hall S, Geusens P, et al.
Conference contribution
SECUKINUMAB PROVIDES SUSTAINED IMPROVEMENTS IN THE SIGNS AND SYMPTOMS OF ACTIVE PSORIATIC ARTHRITIS: 2-YEAR EFFICACY AND SAFETY RESULTS FROM THE PHASE 3 RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL, FUTURE 1 (2016)
Kavanaugh A, Mease P, Reimold A, Tahir H, Rech J, Hall S, Geusens P, et al.
Conference contribution
‹
1
2
›